Send us Feedback

Keryx Biopharmaceuticals (KERX)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING 31-MAR
2012		 30-JUN
2012		 30-SEP
2012		 31-DEC
2012		 31-MAR
2013
Cash & Equivalents 21.7M 21.1M 20.2M 14.7M 87.3M
Short Term Investments 9.21M 6.01M 0 0 0
Accounts Receivable 67.0K 38.0K 0 0 0
Inventories 0 0 0 0 0
Pre-paid Expenses 0 0 0 0 0
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 524K 190K 558K 430K 1.74M
Total Current Assets 31.5M 27.3M 20.8M 15.1M 89.1M
Property, Plant & Equipment 59.0K 51.0K 59.0K 56.0K 91.0K
Goodwill & Intangibles 3.21M 3.21M 3.21M 3.21M 3.21M
Other Long-term Assets 209K 209K 198K 198K 163K
Total Long-Term Assets 3.48M 3.47M 3.46M 3.46M 3.46M
Total Assets 35.0M 30.8M 24.3M 18.6M 92.5M
Accounts Payable 9.56M 8.87M 7.12M 7.21M 8.45M
Accrued Expenses 0 0 0 0 0
Short Term Debt 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 9.74M 9.28M 7.69M 8.04M 8.66M
Long Term Debt 0 0 0 0 0
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 2.66M 11.0K 0 36.0K 24.0K
Total Long-term Liabilities 2.66M 11.0K 0 36.0K 24.0K
Minority Interest 0 0 0 0 0
Total Liabilities 12.4M 9.29M 7.69M 8.07M 8.68M
Preferred Stock 0 0 0 0 0
Common Par 71.0K 72.0K 72.0K 72.0K 82.0K
Additional Paid-In Capital 402M 402M 403M 403M 479M
Retained Earnings -379M -381M -386M -393M -395M
Treasury Stock -357K -357K -357K -357K -357K
Other Equity 0 0 0 0 0
Total Shareholder's Equity 22.6M 21.5M 16.6M 10.5M 83.9M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki